Available to SourceHuman Prescription DrugDiabetes & Endocrine

Ngenla (Somatrogon-Ghla)

24 mg/1.2mL · Injection Solution

By Pfizer Laboratories Div Pfizer Inc

Somatrogon-Ghla · Injectable Solution · 24 mg/1.2mL · Subcutaneous

NDC: 0069-0505
Route: Subcutaneous
Therapeutic class: 11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors [MoA], Human Growth Hormone [CS], Recombinant Human Growth Hormone
Marketing category: BLA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Diabetes & Endocrine

See all →

Ngenla (Somatrogon-Ghla)

Additional information

Request this medication.

Related in Diabetes & Endocrine

Omeosport

Guna-Geriatrics

Procort (1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream)

1% Hydrocortisone